Sara Ollerman
About Sara Ollerman
Sara Ollerman is an Associate Scientist at Invenra in Madison, Wisconsin, where she has worked since 2019. She holds a Bachelor's degree in Cell Biology from the University of Wisconsin-Stevens Point and has extensive experience in biomanufacturing and cellular analysis.
Work at Invenra
Sara Ollerman has been serving as an Associate Scientist at Invenra since 2019. In this role, she has focused on utilizing advanced technologies for metabolite evaluation and cellular analysis, specifically employing the Cedex BioHT Analyzer and Cedex Cell Counter. Her responsibilities include developing standard operating procedures (SOPs) that adhere to Good Manufacturing Practice (GMP) regulations, ensuring compliance and quality in biomanufacturing processes.
Education and Expertise
Sara Ollerman earned her Bachelor's degree in Cell Biology from the University of Wisconsin-Stevens Point, where she studied from 2007 to 2012. Her education has provided her with a strong foundation in cellular processes and methodologies, which she applies in her current role at Invenra. Her expertise includes advanced cellular analysis and the development of SOPs in compliance with industry standards.
Background
Before joining Invenra, Sara Ollerman worked at Catalent Pharma Solutions from 2012 to 2018 as a cGMP Biomanufacturing Cell Bank Coordinator. During her six years there, she was involved in investigating new transfection methods for cell line creation, which improved the efficiency of cell line development. Her role required collaboration with various teams to meet client needs, showcasing her ability to work effectively in cross-functional environments.
Achievements in Biomanufacturing
In her previous position at Catalent Pharma Solutions, Sara Ollerman analyzed the genetic stability of cell lines to ensure production quality. This work contributed to the reliability of biomanufacturing processes, highlighting her commitment to maintaining high standards in the production of biological products. Her efforts in enhancing cell line development and ensuring compliance with cGMP regulations reflect her dedication to the field.